<--- Back to Details
First PageDocument Content
Medicine / Dystonia / Focal dystonia / Job Accommodation Network / Spasmodic torticollis / Movement disorder / Botulinum toxin / Oromandibular dystonia / Blepharospasm / Neurological disorders / Health / Neurology
Date: 2013-03-11 15:52:55
Medicine
Dystonia
Focal dystonia
Job Accommodation Network
Spasmodic torticollis
Movement disorder
Botulinum toxin
Oromandibular dystonia
Blepharospasm
Neurological disorders
Health
Neurology

Accommodation and Compliance Series Employees with Dystonia Preface The Job Accommodation Network (JAN) is a service of the Office of Disability Employment Policy of the U.S. Department of Labor. JAN makes documents ava

Add to Reading List

Source URL: askjan.org

Download Document from Source Website

File Size: 163,62 KB

Share Document on Facebook

Similar Documents

CEREBRAL PALSY – DYSKINESIS Overview The dyskinetic form of cerebral palsy affects a person’s ability to control their movements. This involuntary movement tends to become more pronounced when the person becomes tire

CEREBRAL PALSY – DYSKINESIS Overview The dyskinetic form of cerebral palsy affects a person’s ability to control their movements. This involuntary movement tends to become more pronounced when the person becomes tire

DocID: 17wcl - View Document

Health / Tremor / Essential tremor / Spasmodic dysphonia / Primidone / Movement disorder / Dystonia / The Movement Disorder Society / Spasmodic torticollis / Neurological disorders / Medicine / Neurology

Isolated vocal tremor as a focal phenotype of essential tremor: a retrospective case review

DocID: 15QTB - View Document

Microsoft Word - Merz pharmaceuticals- 5.7 incobotulinumtoxinPSD final.docx

Microsoft Word - Merz pharmaceuticals- 5.7 incobotulinumtoxinPSD final.docx

DocID: 12mqb - View Document

Anatomy / Botulinum toxin / Blepharospasm / Spasmodic torticollis / Dystonia / Spasticity / Focal dystonia / Neurotoxin / Neurological disorders / Medicine / Biology

5.7 INCOBOTULINUMTOXIN A, powder for solution for injection, 100LD50 units, Xeomin®, Merz Pharmaceuticals GmbH. Purpose of Application

DocID: 12hwW - View Document

Health / Deep brain stimulation / Dystonia / Focal dystonia / Tremor / Essential tremor / Neurological disorders / Medicine / Neurology

Title: Deep brain stimulation for dystonia and essential tremor Agency: Medical Services Advisory Committee (MSAC) MDP 106 Commonwealth Department of Health and Ageing GPO Box 9849 Canberra ACT 2601 http://www.msac.gov

DocID: 103y9 - View Document